Shoulder InnovationsSI -3.77%12 PS Ratio is 6.96 as of Jun. 30, 2026, which is 27% above its 10-year median of 5.48. GuruFocus rates SI with a GF Score™ of 12/100. The stock has 5 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Shoulder Innovations ranks worse than 78.36% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Shoulder Innovations's share price is $20.295.
Shoulder Innovations's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $2.92. Hence, Shoulder Innovations's PS Ratio for today is 6.96.
The historical rank and industry rank for Shoulder Innovations's PS Ratio or its related term are showing as below:
SI'
s PS Ratio Range Over the Past 10 Years
Min: 4.45 Med: 5.48 Max: 8.52
Current: 6.95
During the past 3 years, Shoulder Innovations's highest PS Ratio was 8.52. The lowest was 4.45. And the median was 5.48.
SI's PS Ratio is ranked worse than 78.36% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.94
vs SI: 6.95
Shoulder Innovations (NYSE:SI) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Shoulder Innovations PS Ratio Related Terms
Shoulder Innovations PS Ratio Historical Data
* Premium members only.
The historical data trend for Shoulder Innovations's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Shoulder Innovations's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shoulder Innovations PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shoulder Innovations's PS Ratio distribution charts can be found below:
* The bar in red indicates where Shoulder Innovations's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Shoulder Innovations's Share Price of today is $20.295. Shoulder Innovations's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.92.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Shoulder Innovations (SI) has a PS Ratio of 6.96 as of Jun. 30, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Shoulder Innovations and its competitors. This is 27% above median its historical median of 5.48. Over the past decade, Shoulder Innovations' PS Ratio has ranged from 4.45 to 8.52. According to the industry distribution chart, Shoulder Innovations ranks #630 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 78.4%.
Is Shoulder Innovations' PS Ratio too high?
Shoulder Innovations' current PS Ratio of 6.96 is 27% above median its 10-year median of 5.48. Over the past 10 years, this metric has ranged from a low of 4.45 to a high of 8.52. The Medical Devices & Instruments industry median PS Ratio is 2.94. Shoulder Innovations' value of 6.96 is 136.7% above this industry median. Based on the distribution chart, Shoulder Innovations ranks #630 out of 804 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shoulder Innovations has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Shoulder Innovations' PS Ratio compare to MOBI and DCTH?
According to the Medical Devices & Instruments industry distribution chart, Shoulder Innovations ranks #630 out of 804 companies for PS Ratio. This places Shoulder Innovations in the lower half of its industry. The industry median PS Ratio is 2.94. Shoulder Innovations' value of 6.96 is 136.7% above this benchmark. Historically, Shoulder Innovations' own PS Ratio has ranged from 4.45 to 8.52 over the past decade. While the company's 10-year median is 5.48 vs. the industry median of 2.94, Shoulder Innovations has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shoulder Innovations's current PS Ratio of 6.96 is 136.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Shoulder Innovations and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shoulder Innovations's current PS Ratio is 6.96, which is 27% above median its own 10-year median of 5.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shoulder Innovations stock overvalued right now?
Shoulder Innovations (SI) has a current PS Ratio of 6.96. The current PS Ratio is 6.96, which is 27% above median its 10-year median of 5.48 and 136.7% above the Medical Devices & Instruments industry median of 2.94. Shoulder Innovations' overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Shoulder Innovations (SI), the current PS Ratio is 6.96 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
12GF Score
Get the complete analysis for SI
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SI has been successfully added to your 
